Attendees must be registered for Elevate-Derm Fall Conference in order to attend this program.
Saturday, November 15, 2025
5:00 p.m. – 6:00 p.m. ET CE Symposium
JW Marriott Tampa Water Street
510 Water Street
Tampa, Florida 33602
Meeting Location: Tampa Bay 5
PROGRAM FEATURES
- Interactive case-based presentation
- Downloadable whiteboard animation
- Online personalized quality-improvement poster-generation portal
PRESENTING FACULTY
 |
Laura Bush, DMSc, PA-C, DFAAPA Physician Assistant Fayette Area Dermatology Fayetteville, Georgia |
PROGRAM OVERVIEW
This educational symposium is tailored for dermatology clinicians to enhance their expertise in diagnosing and managing of hidradenitis suppurativa (HS). The program will review evidence-based best practices and clinical strategies for early HS diagnosis, emphasizing the transformative role of biologic agents in treatment. It will also explore the practical use of these agents, focusing on individualizing therapy by balancing efficacy, safety, and patient-specific factors.
TARGET AUDIENCE
This educational activity is specifically designed for dermatology NPs and PAs, and dermatologists who care for patients with hidradenitis suppurativa.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Facilitate a timely and accurate diagnosis of HS using evidence-based diagnostic criteria
- Assess the mechanism of action of new and emerging biologic agents for HS in the context of the underlying pathophysiology of the disease
- Interpret efficacy and safety data for new and emerging biologic agents for the treatment of HS
- Develop comprehensive treatment plans in conjunction with patients and multidisciplinary colleagues to address HS and associated comorbidities
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Successful completion of this nursing continuing professional development activity will be awarded 1.0 contact hour and 1.0 contact hour in the area of pharmacology.
AAPA CREDIT DESIGNATION STATEMENT – LIVE
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.
This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
ACCME INNOVATION PARTNER DISCLAIMER
Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity. In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy
AMERICANS WITH DISABILITIES ACT
Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
